T0	Participants 254 346	43 patients with carcinoma of the cervix uteri, all of whom were treated by radical surgery.
T1	Participants 347 453	All patients had carcinoma confined to the cervix, the upper part of the vagina or the parametrial region.
T2	Participants 454 560	When the malignancy had spread to the parametrial region, additional postoperative radiotherapy was given.
T3	Participants 561 693	22 patients received immunotherapy 10 days before surgery, whereas the remaining 21 control patients received no immune stimulation.
T4	Participants 860 930	15 patients with more advanced malignancies were added to our studies.